β¨ Medicines Distribution Consent
4 SEPTEMBER 2008 NEW ZEALAND GAZETTE, No. 136 3623
Dated this 28th day of August 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6450
Consent to the Distribution of a Changed Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Doxine
Active Ingredient: Doxycycline hyclate 115mg equivalent to doxycycline 100mg
Dosage Form: Tablet
New Zealand Sponsor: Pacific Pharmaceuticals Limited (part of Mylan)
Manufacturer: Intas Pharmaceuticals Limited, Matoda, Gujarat, India
Dated this 28th day of August 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6447
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Cubicin
Active Ingredient: Daptomycin 350mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Catalent Pharma Solutions LLC, Albuquerque, New Mexico, United States of America
Product: Cubicin
Active Ingredient: Daptomycin 500mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Catalent Pharma Solutions LLC, Albuquerque, New Mexico, United States of America
Hospira, Inc., McPherson, Kansas, United States of America
Product: Norprolac
Active Ingredients: Quinagolide hydrochloride 0.0273mg equivalent to 0.025mg quinagolide
Quinagolide hydrochloride 0.0546mg equivalent to 0.05mg quinagolide
Dosage Form: Tablet
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturer: Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom
Product: Norprolac
Active Ingredient: Quinagolide hydrochloride 0.1638mg equivalent to quinagolide 0.15mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturer: Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom
Product: Norprolac
Active Ingredient: Quinagolide hydrochloride 0.0819mg equivalent to quinagolide 0.075mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturer: Novartis Pharmaceuticals UK Limited, Horsham, West Sussex, United Kingdom
Dated this 28th day of August 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6446
Consent to the Distribution of a New Related Product
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of a Changed Medicine
π₯ Health & Social Welfare28 August 2008
Medicines, Distribution, Doxine, Doxycycline, Pacific Pharmaceuticals, Intas Pharmaceuticals
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare28 August 2008
Medicines, Distribution, Cubicin, Daptomycin, Norprolac, Quinagolide, Novartis, Pharmaco
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
π₯ Consent to the Distribution of a New Related Product
π₯ Health & Social Welfare28 August 2008
Medicines, Distribution, New Related Product
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
NZ Gazette 2008, No 136